Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Results at the 36 mg dose which became the target dose for Phase 3 showed: - Mean body weight loss: 14.7% - Participants losing 10% or more: approximately 67% - Participants losing 15% or more: approximately 46% The Phase 3 ACHIEVE program extends the treatment duration to 72 weeks with larger sample sizes
Acylcarnitine has been shown to mediate white adipose tissue (WAT)liverBAT crosstalk [219]
Spend the savings on consistency buying a second bottle so you never lapse rather than on a marginally stronger or more expensive formula
PMID: 5321464
Top Tips to Minimise Side Effects Start low, go slow Dont rush dose increases let your body adjust
Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis
